scholarly article | Q13442814 |
P2093 | author name string | W. G. Kramer | |
C. W. Driever | |||
G. A. Frick | |||
R. Ballentine | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | D-(-)-mannitol | Q407646 |
P304 | page(s) | 13-16 | |
P577 | publication date | 1979-01-01 | |
P1433 | published in | Cancer Treatment Reports | Q27710285 |
P1476 | title | Renal excretion kinetics of high-dose cis-dichlorodiammineplatinum(II) administered with hydration and mannitol diuresis | |
P478 | volume | 63 |
Q36355684 | A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity. |
Q46231923 | Acute and long-term nephrotoxicity of cis-platinum in man. |
Q43712532 | Beta-2-microglobulin excretion: an indicator of long term nephrotoxicity during cis-platinum treatment? |
Q51609240 | Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant diseas |
Q67600077 | Calcium blockers enhance cisplatin-induced nephrotoxicity in rats |
Q70667286 | Cisplatin disposition in children and adolescents with cancer |
Q92313119 | Citrus aurantium Ameliorates Cisplatin-Induced Nephrotoxicity |
Q67552719 | Effect of coadministration of selenite on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II) given repeatedly to mice |
Q69934312 | Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum |
Q36424378 | Hydration with magnesium and mannitol without furosemide prevents the nephrotoxicity induced by cisplatin and pemetrexed in patients with advanced non-small cell lung cancer |
Q50074885 | Pharmacokinetic-Pharmacodynamic Analysis of Cisplatin with Hydration and Mannitol Diuresis: The Contribution of Urine Cisplatin Concentration to Nephrotoxicity |
Q39768346 | Pharmacokinetics of anticancer drugs in children |
Q36322728 | Platinum antitumour agents: a review of (bio)analysis |
Q36949303 | Safety of a short hydration method for cisplatin administration in comparison with a conventional method-a retrospective study. |
Q70676378 | [Pharmacokinetic of platin in plasma and urine of man under 1-, 8-, and 24 h-infusion with cis-dichlorodiamine-platin (II) (cis-DDP) (author's transl)] |
Search more.